Results of a study investigating thiotepa added to chemoimmunotherapy for treatment of relapsed primary central nerous system lymphoma.
Home / Resource Library / A phase 1/2 study of thiotepa based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial